Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Elderly Very Poor Performance Status Patients with Aggressive B Cell Lymphomas Can Gain Long Term Remissions with Intensive Chemotherapy with Encouraging Response Rates and Overall Survival (OS).

Stella J Bowcock, MA, MRCP, FRCPath, Vincenzo Fontana, MD, Yvonne Noble, Susan Ward, MBBS, MRCP, FRCPath, Keith Winyard, Cahill Linda, Cathy Mayers, Hannah E Patrick, MBBS, MRCP

Blood (2010) 116 (21): 2794.

https://doi.org/10.1182/blood.V116.21.2794.2794

Published: 2010

Journal Articles

Increased Endothelial Colony-Forming Cells (ECFC) and Endothelial Microparticles (EMP) and Their Interaction in Thrombotic Thrombocytopenic Purpura (TTP).

Joaquin J. Jimenez, MD, Wenche Jy, PhD, Lucia M. Mauro, Loreta Bidot, BS, Luis M. Salgueiro, PhD, David Andrews, MD, Sherry Shariatmadar, MD, Lawrence L. Horstman, BS, Vincenzo Fontana, MD, Yeon-Soong Ahn, MD

Blood (2007) 110 (11): 3908.

https://doi.org/10.1182/blood.V110.11.3908.3908

Published: 2007

Journal Articles

Surface Adhesion and Growth of Microaggregates under Flow Condition (II): Clinical Findings in Patients with Thrombosis and Thrombocytopenia.

Loreta Bidot, BS, Wenche Jy, PhD, Lawrence L. Horstman, BS, Carlos Jr. Bidot, BS, Vincenzo Fontana, MD, Joaquin J. Jimenez, MD, Carlos J. Bidot, MD, Yeon-Soong Ahn, MD

Blood (2007) 110 (11): 3628.

https://doi.org/10.1182/blood.V110.11.3628.3628

Published: 2007

Journal Articles

Cell-Derived Microparticles in ITP Patients with vs. without Bleeding Tendency.

Vincenzo Fontana, MD, Wenche Jy, PhD, Pamela Dudkiewicz, ARNP, Eugene Ahn, MD, Lawrence Horstman, BS, Yeon S. Ahn, MD

Blood (2007) 110 (11): 2092.

https://doi.org/10.1182/blood.V110.11.2092.2092

Published: 2007

Journal Articles

Increased Prevalence of Anti-CD36 and Elevated Endothelial Microparticles in Patients with Recurrent Thrombosis.

Carlos J. Bidot, MD, Wenche Jy, PhD, Camile Ortega, BS, Larry L. Horstman, BS, Carlos Bidot, BS, Loreta Bidot, BS, Cynthia Petit, AA, Vincenzo Fontana, MD, Miriam Yaniz, MS, Yeon-Soong Ahn, MD

Blood (2007) 110 (11): 1632.

https://doi.org/10.1182/blood.V110.11.1632.1632

Published: 2007

Journal Articles

Elevated Red Cell Microparticles (RMP) as Risk Factor for Thrombosis in Patients with Renal Failure.

Vincenzo Fontana, MD, Wenche Jy, PhD, Lawrence Horstman, BS, Dudkiewicz Pamela, ARNP, Fernandez Carina, AS, Carlos Bidot, Jr., BS, Ahn S. Ahn, MD

Blood (2007) 110 (11): 1638.

https://doi.org/10.1182/blood.V110.11.1638.1638

Published: 2007

Journal Articles

Effects of Intravenous Immunoglobulins (IVIG) on Cell-Derived Microparticles in Patients with ITP.

Vincenzo Fontana, MD, Wenche Jy, PhD, Eugene Ahn, MD, Loreta Bidot, MT, Pamela Dudkiewicz, ARNP, Lawrence Horstman, BS, Yeon S. Ahn, MD

Blood (2007) 110 (11): 3134.

https://doi.org/10.1182/blood.V110.11.3134.3134

Published: 2007

Journal Articles

Recurrence of Severe ITP Following Administration of G-CSF: Remission Following Platelet and Vinca-Alkaloid Infusion.

Eugene R. Ahn, MD, John J. Byrnes, MD, Vincenzo Fontana, MD, Pamela Dudkiewicz, ARNP, Carlos J. Bidot, MD, Yeon S. Ahn, MD

Blood (2007) 110 (11): 3222.

https://doi.org/10.1182/blood.V110.11.3222.3222

Published: 2007

Journal Articles

Cell-Derived Microparticle (C-MP) Profiles in Lymphoproliferative Disorders: Association of Elevated Red Cell Microparticles (RMP) with Thrombosis.

Vincenzo Fontana, MD, J.Y. Wenche, PhD, Lawrence Horstman, BS, Pamela Dudkiewicz, ARNP, Joaquim Jimenez, MD, Ahn S. Ahn, MD

Blood (2007) 110 (11): 3988.

https://doi.org/10.1182/blood.V110.11.3988.3988

Published: 2007

Journal Articles

Recurrent Thrombosis Is Frequently Associated with Increased Microparticle-Mediated Thrombin Generation.

Loreta Bidot, BS, Wenche Jy, PhD, Carlos Bidot, Jr., AA, Vincenzo Fontana, MD, Lawrence L. Horstman, BS, Eugene Ahn, MD, Carlos J. Bidot, MD, Yeon-Soong Ahn, MD

Blood (2006) 108 (11): 1479.

https://doi.org/10.1182/blood.V108.11.1479.1479

Published: 2006

Journal Articles

Cell-Derived Microparticles (C-MP) Are Elevated in Splenectomized Patients and Depressed in Those with Hypersplenism, Suggesting Spleen as Scavenger of C-MP.

Vincenzo Fontana, MD, Wenche Jy, PhD, Pamela Dudkiewicz, ARNP, Lawrence L. Horstman, BS, Carlos Bidot, Jr., AA, Yeon-Soong Ahn, MD

Blood (2006) 108 (11): 1482.

https://doi.org/10.1182/blood.V108.11.1482.1482

Published: 2006

Journal Articles

Elevated Cell-Derived Microparticles (C-MP) in Myeloproliferative Disorders (MPD): High Red Cell Microparticles (RMP) as Risk Factor for Thrombosis.

Vincenzo Fontana, MD, Wenche Jy, PHD, Pamela Dudkiewicz, ARNP, Bidot Loreta, BS, Martha Gonzalez, MT, Myriam Yaniz, MS, Yeon-Soong Ahn, MD

Blood (2006) 108 (11): 1483.

https://doi.org/10.1182/blood.V108.11.1483.1483

Published: 2006

Journal Articles

Profile of Cell-Derived Microparticles (C-MP) in ITP: Red Cell Microparticles (RMP) Correlate with Severity of ITP.

Vincenzo Fontana, MD, Pamela Dudkiewicz, ARNP, Eugene Ahn, MD, Wenche Jy, PhD, Lawrence L. Horstman, BS, Myriam Yaniz, MS, Yeon-Soong Ahn, MD

Blood (2006) 108 (11): 1087.

https://doi.org/10.1182/blood.V108.11.1087.1087

Published: 2006

Journal Articles

Antibodies Against Platelet Glycoprotein Target Antigens in Antiphospholipid Syndrome (APS).

Carlos J. Bidot, MD, Wenche Jy, PhD, Carlos Bidot, Jr., Lawrence L. Horstman, BS, Vincenzo Fontana, MD, Miriam Yaniz, MS, Martha Gonzalez, MT, Yeon S. Ahn, MD

Blood (2006) 108 (11): 3973.

https://doi.org/10.1182/blood.V108.11.3973.3973

Published: 2006

Journal Articles

Danazol with Intermittent Chemotherapy Induces Lasting Remissions in Advanced and Refractory MPD in Elderly Patients.

Vincenzo Fontana, MD, Eugene Ahn, MD, Pamela Dudkiewicz, ARNP, Lawrence L. Horstman, BS, Carina Fernandez, AS, Yeon-Soong Ahn, MD

Blood (2006) 108 (11): 4887.

https://doi.org/10.1182/blood.V108.11.4887.4887

Published: 2006

Journal Articles

Evidence of Different Subspecies of Microparticles (MP) Derived from Red Blood Cells (RMP) and Comparison of Their Phenotypes and Procoagulant Activity.

Wenche Jy, PhD, Jaehoon Bang, Loreta Bidot, BS, Andrew Lin, Joaquin J. Jimenez, MD, Vincenzo Fontana, MD, Eugene Ahn, MD, Yeon-Soong Ahn, MD

Blood (2006) 108 (11): 1763.

https://doi.org/10.1182/blood.V108.11.1763.1763

Published: 2006

Journal Articles

Activation of Clotting Factors in Thrombocytopenia Due to Platelets Destruction: A Possible Compensated Mechanism for Hemostasis.

Vincenzo Fontana, MD, Wenche Jy, PhD, Eugene Ahn, MD, Pamela Dudkiewicz, ARNP, Lawrence L. Horstman, BS, Carlos J. Bidot, MD, Yeon S. Ahn, MD

Blood (2005) 106 (11): 3999.

https://doi.org/10.1182/blood.V106.11.3999.3999

Published: 2005

Journal Articles

Rituximab Therapy Induces Long Lasting Clinical Remissions and Reduction of Anti-Platelet Glycoprotein Autoantibodies in Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

Eugene R. Ahn, MD, Carlos J. Bidot, MD, Vincenzo Fontana, MD, Pamela Dudkiewicz, RN, Wenche Jy, PhD, Lawrence Horstman, BS, Yeon S. Ahn, MD

Blood (2005) 106 (11): 4006.

https://doi.org/10.1182/blood.V106.11.4006.4006

Published: 2005

Journal Articles

New Role of Antiphospholipid Antibodies (APLA)? Correlations with Disease Activity in Non-Thrombotic and Thrombotic Autoimmune and Hematologic Disorders.

Lawrence L. Horstman, BS, Carlos J. Bidot, MD, Wenche Jy, PhD, Vincenzo Fontana, MD, Pamela Duckiewicz, ARNP, Eugene R. Ahn, MD, Joaquin J. Jimenez, MD, Yeon S. Ahn, MD

Blood (2005) 106 (11): 2649.

https://doi.org/10.1182/blood.V106.11.2649.2649

Published: 2005

Journal Articles

Profiles of Antibodies Specific to Platelet Glycoproteins in ITP Differ in Remission, Relapse and Stable Phases; and Anti-GpIIb/IIIa, -GpIb/IX Were Associated with Bleeding Manifestations.

Carlos J. Bidot, MD, Wenche Jy, PhD, Lawrence L. Horstman, BS, Eugene Ahn, MD, Vincenzo Fontana, MD, Yisel Valdes, Rayden Llano, Loreta Bidot, Yeon S. Ahn, MD

Blood (2005) 106 (11): 1250.

https://doi.org/10.1182/blood.V106.11.1250.1250

Published: 2005

NARROW

Elderly Very Poor Performance Status Patients with Aggressive B Cell Lymphomas Can Gain Long Term Remissions with Intensive Chemotherapy with Encouraging Response Rates and Overall Survival (OS).

Increased Endothelial Colony-Forming Cells (ECFC) and Endothelial Microparticles (EMP) and Their Interaction in Thrombotic Thrombocytopenic Purpura (TTP).

Surface Adhesion and Growth of Microaggregates under Flow Condition (II): Clinical Findings in Patients with Thrombosis and Thrombocytopenia.

Cell-Derived Microparticles in ITP Patients with vs. without Bleeding Tendency.

Increased Prevalence of Anti-CD36 and Elevated Endothelial Microparticles in Patients with Recurrent Thrombosis.

Elevated Red Cell Microparticles (RMP) as Risk Factor for Thrombosis in Patients with Renal Failure.

Effects of Intravenous Immunoglobulins (IVIG) on Cell-Derived Microparticles in Patients with ITP.

Recurrence of Severe ITP Following Administration of G-CSF: Remission Following Platelet and Vinca-Alkaloid Infusion.

Cell-Derived Microparticle (C-MP) Profiles in Lymphoproliferative Disorders: Association of Elevated Red Cell Microparticles (RMP) with Thrombosis.

Recurrent Thrombosis Is Frequently Associated with Increased Microparticle-Mediated Thrombin Generation.

Cell-Derived Microparticles (C-MP) Are Elevated in Splenectomized Patients and Depressed in Those with Hypersplenism, Suggesting Spleen as Scavenger of C-MP.

Elevated Cell-Derived Microparticles (C-MP) in Myeloproliferative Disorders (MPD): High Red Cell Microparticles (RMP) as Risk Factor for Thrombosis.

Profile of Cell-Derived Microparticles (C-MP) in ITP: Red Cell Microparticles (RMP) Correlate with Severity of ITP.

Antibodies Against Platelet Glycoprotein Target Antigens in Antiphospholipid Syndrome (APS).

Danazol with Intermittent Chemotherapy Induces Lasting Remissions in Advanced and Refractory MPD in Elderly Patients.

Evidence of Different Subspecies of Microparticles (MP) Derived from Red Blood Cells (RMP) and Comparison of Their Phenotypes and Procoagulant Activity.

Activation of Clotting Factors in Thrombocytopenia Due to Platelets Destruction: A Possible Compensated Mechanism for Hemostasis.

Rituximab Therapy Induces Long Lasting Clinical Remissions and Reduction of Anti-Platelet Glycoprotein Autoantibodies in Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

New Role of Antiphospholipid Antibodies (APLA)? Correlations with Disease Activity in Non-Thrombotic and Thrombotic Autoimmune and Hematologic Disorders.

Profiles of Antibodies Specific to Platelet Glycoproteins in ITP Differ in Remission, Relapse and Stable Phases; and Anti-GpIIb/IIIa, -GpIb/IX Were Associated with Bleeding Manifestations.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only